A novel mouse model of endometriosis: Simulating the recurrent hemorrhagic microenvironment of clinical lesions

Abstract

Current models of endometriosis (EMs) still have limitations in replicating the key pathological features of human EMs, particularly the cyclic bleeding associated with ectopic lesions. To address this gap, this study aimed to develop a proof-of-concept mouse model that incorporates repeated retrograde hemorrhagic exposure through the intraperitoneal injection of endometrial fragments, followed by repeated intraperitoneal injections of fresh whole blood. An EMs model was established in female C57BL/6J mice via intraperitoneal injection of endometrial fragments combined with saline or whole blood, respectively. The model was systematically evaluated using ectopic lesion burden, peritoneal adhesion scores, histopathological staining, immunohistochemistry, enzyme-linked immunosorbent assay (ELISA), and quantitative reverse transcription polymerase chain reaction (RT-qPCR). Both models successfully recapitulated the fundamental pathological features of EMs. However, the intraperitoneal injection of whole blood (IPBI) protocol induced a markedly greater lesion burden, together with more pronounced histopathological and molecular alterations, and recapitulated repeated exposure to retrograde menstruation. In addition, the IPBI group exhibited more robust systemic biomarker responses, indicating enhanced clinical relevance. The present study successfully established a proof-of-concept EMs mouse model that introduces repeated retrograde hemorrhagic exposure to create a clinically relevant, blood-stimulated microenvironment. This model provides a reliable tool for investigating the pathogenesis of EMs and developing therapeutic strategies.

Keywords

ectopic lesion / endometriosis / mouse model / recurrent hemorrhage

References

[1] Griffiths MJ, Horne AW, Gibson DA, Roberts N, Saunders PTK. Endometriosis: recent advances that could accelerate diagnosis and improve care. Trends Mol Med. 2024; 30(9): 875-889.

[2] Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020; 382(13): 1244-1256.

[3] Blanco LP, Salmeri N, Temkin SM, Shanmugam VK, Stratton P. Endometriosis and autoimmunity. Autoimmun Rev. 2025; 24(4):103752.

[4] Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022; 2022(2):hoac009.

[5] Sampson J. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into peritoneal cavity. Am J Obstet Gynecol. 1927; 14: 422-469.

[6] Meyer R. Üeber den stand der Frage der Adenomyositis und Adenomyome in algemeinen und insbesondere über ber Adenomyositis serosoepithelialis und Adenomyometritis sarcomatosa. Zbl Gynäkol. 1919; 43: 745-750.

[7] Ueki M. Histologic study of endometriosis and examination of lymphatic drainage in and from the uterus. Am J Obstet Gynecol. 1991; 165(1): 201-209.

[8] Merrill JA. Endometrial induction of endometriosis across Millipore filters. Am J Obstet Gynecol. 1966; 94(6): 780-790.

[9] He Y, Liang B, Hung SW, et al. Re-evaluation of mouse models of endometriosis for pathological and immunological research. Front Immunol. 2022; 13:986202.

[10] Grümmer R. Animal models in endometriosis research. Hum Reprod Update. 2006; 12(5): 641-649.

[11] Coté J, Coté R, Zent I, et al. Immunocompetent mouse models of endometriosis: a systematic review and meta-analysis. F&S Rev. 2025; 6(2):100091.

[12] Wang CC, Xu H, Man GC, et al. Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Angiogenesis. 2013; 16(1): 59-69.

[13] Zeng Y, Hang F, Peng C, et al. Research progress in rodent models of endometriosis. J Reprod Immunol. 2024; 163:104219.

[14] Burns KA, Pearson AM, Slack JL, et al. Endometriosis in the mouse: challenges and progress toward a ‘best fit’ murine model. Front Physiol. 2022; 12:806574.

[15] McCallion A, Nasirzadeh Y, Lingegowda H, et al. Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology. Front Immunol. 2022; 13:961599.

[16] Park Y, Cho YJ, Sung N, et al. Oleuropein suppresses endometriosis progression and improves the fertility of mice with endometriosis. J Biomed Sci. 2022; 29(1): 100.

[17] Ates C, Dilbaz B, Ergani SY, et al. The effect of antiangiogenic agent aflibercept on surgically induced endometriosis in a rat model. Cir Cir. 2024; 92(1): 10-19.

[18] D'Amico R, Impellizzeri D, Cordaro M, et al. Regulation of apoptosis and oxidative stress by oral Boswellia serrata gum resin extract in a rat model of endometriosis. Int J Mol Sci. 2022; 23(23):15348.

[19] Mariadas H, Chen JH, Chen KH. The molecular and cellular mechanisms of endometriosis: from basic pathophysiology to clinical implications. Int J Mol Sci. 2025; 26(6):2458.

[20] Tayade S, Rai S, Pai H, Patel M, Makhija N. Efficacy of dienogest in adolescent endometriosis: a narrative review. Cureus. 2023; 15(3):e36729.

[21] Viganò P, Ottolina J, Bartiromo L, et al. Cellular components contributing to fibrosis in endometriosis: a literature review. J Minim Invasive Gynecol. 2020; 27(2): 287-295.

[22] Park SJ, Cho SW, Kim SM, et al. Assessment of myocardial fibrosis using multimodality imaging in severe aortic stenosis: comparison with histologic fibrosis. JACC Cardiovasc Imaging. 2019; 12(1): 109-119.

[23] Scheck S, Paterson ESJ, Henry CE. A promising future for endometriosis diagnosis and therapy: extracellular vesicles—a systematic review. Reprod Biol Endocrinol. 2022; 20(1): 174.

[24] Nishimoto-Kakiuchi A, Sato I, Nakano K, et al. A long-acting anti-IL-8 antibody improves inflammation and fibrosis in endometriosis. Sci Transl Med. 2023; 15(684):eabq5858.

[25] Viganò P, Gaffuri B, Somigliana E, et al. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod. 1998; 4(12): 1150-1156.

[26] Zhang J, Li H, Yi D, et al. Knockdown of vascular cell adhesion molecule 1 impedes transforming growth factor beta 1-mediated proliferation, migration, and invasion of endometriotic cyst stromal cells. Reprod Biol Endocrinol. 2019; 17(1): 69.

[27] Pitsos M, Kanakas N. The role of matrix metalloproteinases in the pathogenesis of endometriosis. Reprod Sci. 2009; 16(8): 717-726.

[28] Klemmt PA, Carver JG, Koninckx P, et al. Endometrial cells from women with endometriosis have increased adhesion and proliferative capacity in response to extracellular matrix components: towards a mechanistic model for endometriosis progression. Hum Reprod. 2007; 22(12): 3139-3147.

[29] Lee J, Banu SK, Burghardt RC, et al. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms. Biol Reprod. 2013; 88(3):77.

[30] Hoffmann-Młodzianowska M, Maksym RB, Pucia K, Kuciak M, Mackiewicz A, Kieda C. Endometriosis development in relation to hypoxia: a murine model study. Mol Med. 2024; 30(1): 195.

[31] Xu H, Becker CM, Lui WT, et al. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril. 2011; 96(4): 1021-1028.

[32] Bordin L, Fiore C, Donà G, et al. Evaluation of erythrocyte band 3 phosphotyrosinelevel, glutathione content, CA-125, and human epididymal secretory protein E4 as combined parameters in endometriosis. Fertil Steril. 2010; 94(5): 1616-1621.

[33] Hirsch M, Duffy J, Davis CJ, et al. International collaboration to harmonise outcomes and measures for endometriosis. Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis. BJOG. 2016; 123(11): 1761-1768.

[34] Barbieri RL, Niloff JM, Bast RC Jr, Schaetzl E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril. 1986; 45(5): 630-634.

[35] Zheng R, Zeng D, Wan TT, et al. Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis. Diagn Interv Radiol. 2018; 24(6): 364-371.

Rights & permissions

2026 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.